GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Net Margin %

Laurus Labs (BOM:540222) Net Margin % : 5.25% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Laurus Labs's Net Income for the three months ended in Mar. 2024 was ₹756 Mil. Laurus Labs's Revenue for the three months ended in Mar. 2024 was ₹14,397 Mil. Therefore, Laurus Labs's net margin for the quarter that ended in Mar. 2024 was 5.25%.

The historical rank and industry rank for Laurus Labs's Net Margin % or its related term are showing as below:

BOM:540222' s Net Margin % Range Over the Past 10 Years
Min: 3.18   Med: 8.82   Max: 20.82
Current: 3.19


BOM:540222's Net Margin % is ranked worse than
50.29% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.255 vs BOM:540222: 3.19

Laurus Labs Net Margin % Historical Data

The historical data trend for Laurus Labs's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Net Margin % Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.25 20.82 16.93 13.08 3.18

Laurus Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.46 2.10 3.02 1.94 5.25

Competitive Comparison of Laurus Labs's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Net Margin % distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Net Margin % falls into.



Laurus Labs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Laurus Labs's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1605.5/50408.3
=3.18 %

Laurus Labs's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=756.1/14396.7
=5.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laurus Labs  (BOM:540222) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Laurus Labs Net Margin % Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines